Guro Lillemoen Andersen

Guro Lillemoen Andersen holds the position of Associate Professor in the Department of Clinical and Molecular Medicine at the Norwegian University of Science and Technology (NTNU). She is also a Senior Consultant at the Habilitation Center and leads the Norwegian Quality and Surveillance Registry for Cerebral Palsy (NorCP). Her work integrates clinical practice, research, and public health initiatives.

Her research focuses on cerebral palsy epidemiology, risk factors, and longitudinal health outcomes. Key interests include studying prenatal, neonatal, and postneonatal risk factors; the impact of cerebral palsy on quality of life; and optimizing healthcare service utilization for affected individuals. Collaborations include the Surveillance of Cerebral Palsy in Europe (SCPE) and the CP-North initiative, which examines Nordic populations.

Notable contributions include analyzing disparities in cerebral palsy prevalence among immigrant populations, evaluating botulinum toxin efficacy for mobility improvements, and investigating comorbidities like epilepsy and pain management. Her work emphasizes evidence-based clinical guidelines and registry-based surveillance to improve care standards and inform policy.

• Education: Medical degree from NTNU (not explicitly stated but inferred from role)
• Leadership: Director of NorCP and SCPE collaborator
• Grants: Multiple studies funded through Norwegian and international health research programs
• Labs/Teams: Research groups include CP-North, CPPain Program, and SCPE

Future work aims to expand longitudinal studies on lifespan outcomes and address healthcare equity for individuals with cerebral palsy and their families.